• LAST PRICE
    2.1600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.0500/ 1
  • Ask / Lots
    2.2200/ 1
  • Open / Previous Close
    0.0000 / 2.1600
  • Day Range
    ---
  • 52 Week Range
    Low 1.1750
    High 9.7200
  • Volume
    3,229
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 2.18
TimeVolumePMVP
09:32 ET16732.17
09:36 ET48442.18
09:38 ET465572.1913
09:39 ET34342.2001
09:41 ET56902.19
09:43 ET31852.19
09:45 ET4002.185
09:48 ET220862.2201
09:50 ET579922.235
09:52 ET11022.225
09:54 ET110422.22
09:56 ET8002.21
09:59 ET1002.21
10:03 ET6122.22
10:08 ET46942.24
10:10 ET116132.235
10:12 ET79932.24
10:14 ET56002.25
10:15 ET34392.23
10:17 ET71392.22
10:19 ET7262.215
10:24 ET14002.22
10:26 ET3002.215
10:28 ET55352.21
10:30 ET1002.21
10:32 ET5212.204
10:33 ET15432.205
10:35 ET12002.205
10:37 ET5732.21
10:42 ET2002.22
10:44 ET5502.22
10:46 ET15002.22
10:48 ET1502.22
10:50 ET27302.225
10:53 ET3502.225
10:55 ET4002.23
11:00 ET2002.23
11:02 ET4332.225
11:04 ET1002.23
11:08 ET5502.23
11:11 ET49002.23
11:13 ET2002.23
11:18 ET1002.23
11:22 ET3002.225
11:26 ET75622.22
11:29 ET3002.21
11:33 ET1002.215
11:36 ET1002.215
11:40 ET45732.215
11:42 ET68842.2
11:45 ET20002.2001
11:47 ET110402.21
11:49 ET4002.22
11:56 ET1002.215
11:58 ET7002.214
12:03 ET1002.22
12:05 ET3202.215
12:07 ET3992.215
12:09 ET7002.215
12:12 ET3002.22
12:16 ET2002.215
12:18 ET1002.215
12:23 ET2002.22
12:27 ET1002.215
12:30 ET1002.21
12:36 ET2002.22
12:45 ET1002.21
12:48 ET2002.22
12:56 ET1002.215
12:59 ET48402.215
01:01 ET3002.21
01:06 ET24042.21
01:10 ET67722.2
01:12 ET53942.185
01:15 ET1002.185
01:19 ET2002.185
01:21 ET43402.185
01:24 ET1032.195
01:28 ET3002.19
01:30 ET47632.21
01:32 ET42982.204
01:33 ET88892.2006
01:37 ET8002.21
01:39 ET1002.21
01:42 ET53192.21
01:44 ET5002.21
01:48 ET1002.21
01:50 ET45002.2005
01:51 ET4252.21
01:53 ET1252.21
01:55 ET3802.205
01:57 ET98492.195
02:00 ET1742.1905
02:02 ET1002.195
02:06 ET1002.195
02:11 ET1002.195
02:13 ET128122.21
02:15 ET43512.2006
02:18 ET83242.2006
02:20 ET2002.21
02:24 ET2002.205
02:26 ET21842.205
02:27 ET115982.204
02:29 ET5512.21
02:31 ET143022.2005
02:33 ET4002.21
02:36 ET2002.205
02:40 ET1002.21
02:42 ET86482.2
02:44 ET3002.205
02:45 ET5002.21
02:47 ET129812.195
02:49 ET2002.1905
02:51 ET1002.195
02:54 ET1002.195
02:56 ET14022.195
02:58 ET45982.19
03:00 ET6002.194
03:02 ET72052.185
03:03 ET34332.18
03:05 ET70522.165
03:07 ET172982.15
03:09 ET23562.135
03:12 ET8462.135
03:14 ET32442.115
03:16 ET1452.115
03:18 ET2002.115
03:20 ET151722.12
03:21 ET17662.125
03:23 ET2002.125
03:25 ET4212.125
03:27 ET2392.125
03:30 ET36452.12
03:32 ET2002.13
03:34 ET104442.12
03:36 ET159532.125
03:38 ET93352.12
03:39 ET12002.1249
03:41 ET111132.135
03:43 ET76752.15
03:45 ET151762.18
03:48 ET206982.185
03:50 ET218932.155
03:52 ET98702.165
03:54 ET10002.17
03:56 ET29002.165
03:57 ET411062.165
03:59 ET128302.16
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPMVP
PMV Pharmaceuticals Inc
111.1M
-1.5x
---
United StatesALLK
Allakos Inc
111.6M
-0.6x
---
United StatesLPTX
Leap Therapeutics Inc
114.4M
-0.6x
---
United StatesIMUX
Immunic Inc
114.4M
-0.6x
---
United StatesRLMD
Relmada Therapeutics Inc
115.6M
-1.2x
---
United StatesRZLT
Rezolute Inc
117.2M
-2.6x
---
As of 2024-05-09

Company Information

PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a tumor suppressor protein known as the guardian of the genome, and normal, or wild type, p53 has the ability to eliminate cancer cells. It is leveraging its precision oncology platform to develop a pipeline of orally available, potent and highly selective small molecule product candidates that target p53 mutations or other p53-related cancers. Its lead product candidate, PC14586 (rezatapopt), is an orally available small molecule designed to potently and selectively correct p53 misfolding caused by a specific p53 mutation, Y220C, while sparing wild type p53. In preclinical studies, PC14586 has shown selective on-target activity, which functions in cells with the p53 Y220C mutation and exhibited robust anti-tumor activity evidenced by potent tumor growth inhibition and strong tumor regression as a single agent.

Contact Information

Headquarters
One Research WayPRINCETON, NJ, United States 08540
Phone
609-642-6664
Fax
302-636-5454

Executives

Independent Chairman of the Board
Richard Heyman
Co-Founder, Director
David Mack
Chief Financial Officer, Principal Accounting Officer
Michael Carulli
Chief Marketing Officer
Leila Alland
Chief Regulatory, Quality Assurance Officer
Deepika Jalota

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$111.1M
Revenue (TTM)
$0.00
Shares Outstanding
51.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.59
EPS
$-1.44
Book Value
$4.39
P/E Ratio
-1.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.